References:
1. Cooper Jr LT, Berry GJ,
Shabetai R. Idiopathic giant-cell myocarditis—natural history and
treatment. New England Journal of Medicine.1997;336(26):1860-1866.
2. Fallon JM, Parker AM, Dunn
SP, Kennedy JL. A giant mystery in giant cell myocarditis: navigating
diagnosis, immunosuppression, and mechanical circulatory support.ESC heart failure. 2020;7(1):316-320.
3. Meyer T, Grumbach IM,
Kreuzer H, Morguet AJ. Giant cell myocarditis due to coxsackie B2 virus
infection. Cardiology. 1997;88(3):296-299.
4. Xu J, Brooks EG. Giant
cell myocarditis: a brief review. Archives of pathology &
laboratory medicine. 2016;140(12):1429-1434.
5. Mele D, Flamigni F,
Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current
problems. Internal and Emergency Medicine. 2021:1-7.
6. Rathore SS, Rojas GA,
Sondhi M, et al. Myocarditis associated with Covid-19 disease: A
systematic review of published case reports and case series.International Journal of Clinical Practice. n/a(n/a):e14470.
7. Shi S, Qin M, Cai Y, et
al. Characteristics and clinical significance of myocardial injury in
patients with severe coronavirus disease 2019. European heart
journal. 2020;41(22):2070-2079.
8. Yang F, Cao S, Liu X,
Xiang Y, Zhao Q. Characteristics and clinical significance of myocardial
injury in patients with severe coronavirus disease 2019. European
Heart Journal. 2020;41:2070-2079.
9. Blagova O, Ainetdinova D,
Sedov A, et al. Progressive chronic SARS‐CoV‐2‐positive giant cell
myoendocarditis with atrial standstill and sudden cardiac death.ESC Heart Failure. 2021.
10. Agdamag ACC, Edmiston
JB, Charpentier V, et al. Update on COVID-19 myocarditis.Medicina. 2020;56(12):678.
11. Blauwet LA, Cooper LT.
Myocarditis. Progress in cardiovascular diseases.2010;52(4):274-288.
12. Ramandi MMA,
Yarmohammadi H, Beikmohammadi S, et al. Comparison of the cardiovascular
presentations, complications and outcomes following different
coronaviruses’ infection: A systematic review. Journal of
Cardiovascular and Thoracic Research. 2021;13(2):92-101.
13. Bang V, Ganatra S, Shah
SP, et al. Management of Patients With Giant Cell Myocarditis.Journal of the American College of Cardiology.2021;77(8):1122-1134.
14. Cooper Jr LT, Hare JM,
Tazelaar HD, et al. Usefulness of immunosuppression for giant cell
myocarditis. The American journal of cardiology.2008;102(11):1535-1539.
15. Ekström K,
Räisänen‐Sokolowski A, Lehtonen J, Nordenswan HK, Mäyränpää MI, Kupari
M. Idiopathic giant cell myocarditis or cardiac sarcoidosis? A
retrospective audit of a nationwide case series. ESC heart
failure. 2020;7(3):1362-1370.
16. Kandolin R, Lehtonen J,
Salmenkivi K, Räisänen-Sokolowski A, Lommi J, Kupari M. Diagnosis,
treatment, and outcome of giant-cell myocarditis in the era of combined
immunosuppression. Circulation: Heart Failure. 2013;6(1):15-22.
17. Baykal Selcuk L, Sahin
M, Arıca DA, Orem A, Karaca Ural Z, Yaylı S. Impairment of myocardial
functions and arterial stiffness in patients with lichen planus☆,☆☆.Anais brasileiros de dermatologia. 2020;95:180-186.
18. Gonzalez JG, Marcus MD,
Santa Cruz DJ. Giant cell lichenoid dermatitis. Journal of the
American Academy of Dermatology. 1986;15(1):87-92.
19. Goldberg LJ, Goldberg N,
Abrahams I, Silvers DN, Szaniawski W, Halperin AJ. Giant cell lichenoid
dermatitis: A possible manifestation of sarcoidosis. Journal of
Cutaneous Pathology. 1994;21(1):47-51.
20. Birnie DH, Nair V,
Veinot JP. Cardiac Sarcoidosis and Giant Cell Myocarditis: Actually, 2
Ends of the Same Disease? Journal of the American Heart
Association. 2021;10(6):e020542.
21. Jiang GY, Cai Q, Grandin
EW, Sabe MA. Fulminant cardiac sarcoidosis resembling giant cell
myocarditis: a case report. European Heart Journal - Case
Reports. 2021;5(3).
22. Nordenswan HK, Lehtonen
J, Ekström K, et al. Manifestations and outcome of cardiac sarcoidosis
and idiopathic giant cell myocarditis by 25‐year nationwide cohorts.Journal of the American Heart Association. 2021;10(6):e019415.
23. Okura Y, Dec GW, Hare
JM, et al. A clinical and histopathologic comparison of cardiac
sarcoidosis and idiopathic giant cell myocarditis. Journal of the
American College of Cardiology. 2003;41(2):322-329.
24. Schaller T, Hirschbühl
K, Burkhardt K, et al. Postmortem examination of patients with COVID-19.Jama. 2020;323(24):2518-2520.
25. Varga Z, Flammer AJ,
Steiger P, et al. Endothelial cell infection and endotheliitis in
COVID-19. The Lancet. 2020;395(10234):1417-1418.
26. Diaz GA, Parsons GT,
Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and
pericarditis after vaccination for COVID-19. JAMA. 2021.
27. Hudson B, Mantooth R,
DeLaney M. Myocarditis and pericarditis after vaccination for COVID‐19.Journal of the American College of Emergency Physicians Open.2021;2(4).